Identification on preventive mechanism of glucagon-like peptide-1 (GLP-1) agonist for atherosclerosis model

S.-G. Lee, J.-S. Kim,H.-J. Lee,S.-J. Lee, L. Oh-Hyun,C.-K. Kim

Atherosclerosis(2023)

Cited 0|Views1
No score
Abstract
Background and Aims: The glucagon-like peptide-1 (GLP-1) agonist, a new class of diabetic medication, reduces progression of atherosclerosis lesions. However, mechanism for the protective effect has not been clearly identified. Therefore, we sought to investigate an anti-atherosclerotic and anti-inflammatory mechanism of GLP-1 in atherosclerosis model.
More
Translated text
Key words
agonist,glucagon-like
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined